Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18–49 Years at Increased Risk of RSV Disease Compared with Adults Aged ≥60 Years. - Mitha, Essack; Ferguson, Murdo; Wilhase, Agatha Cathrine; Looze, Ferdinandus De; Vachon, Marie-Louise; Stacey, Helen; Rasalam, Roy; Nozaki, Minoru; Smith, William B; Schwarz, Tino F (Clinical Infectious Diseases, 2026)